Annual EBIT
-$81.41 M
-$27.02 M-49.67%
December 31, 2023
Summary
- As of February 7, 2025, LPTX annual earnings before interest & taxes is -$81.41 million, with the most recent change of -$27.02 million (-49.67%) on December 31, 2023.
- During the last 3 years, LPTX annual EBIT has fallen by -$53.94 million (-196.30%).
- LPTX annual EBIT is now -949.69% below its all-time high of -$7.76 million, reached on December 31, 2012.
Performance
LPTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$18.35 M
+$2.65 M+12.60%
September 30, 2024
Summary
- As of February 7, 2025, LPTX quarterly earnings before interest & taxes is -$18.35 million, with the most recent change of +$2.65 million (+12.60%) on September 30, 2024.
- Over the past year, LPTX quarterly EBIT has dropped by -$8.04 million (-77.90%).
- LPTX quarterly EBIT is now -346.30% below its all-time high of $7.45 million, reached on December 31, 2015.
Performance
LPTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$64.25 M
-$4.08 M-6.77%
September 30, 2024
Summary
- As of February 7, 2025, LPTX TTM earnings before interest & taxes is -$64.25 million, with the most recent change of -$4.08 million (-6.77%) on September 30, 2024.
- Over the past year, LPTX TTM EBIT has increased by +$17.16 million (+21.08%).
- LPTX TTM EBIT is now -3297.62% below its all-time high of -$1.89 million, reached on March 31, 2013.
Performance
LPTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
LPTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -49.7% | -77.9% | +21.1% |
| 3 y3 years | -196.3% | +56.8% | +25.7% |
| 5 y5 years | -252.5% | +56.8% | +25.7% |
LPTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.7% | at low | -77.9% | +56.8% | -58.4% | +25.7% |
| 5 y | 5-year | -196.3% | at low | -182.2% | +56.8% | -133.8% | +25.7% |
| alltime | all time | -949.7% | at low | -346.3% | +56.8% | -3297.6% | +25.7% |
Leap Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$18.35 M(-12.6%) | -$64.25 M(+6.8%) |
| Jun 2024 | - | -$21.00 M(+44.0%) | -$60.17 M(+12.4%) |
| Mar 2024 | - | -$14.58 M(+41.3%) | -$53.54 M(-34.2%) |
| Dec 2023 | -$81.41 M(+49.7%) | -$10.32 M(-27.7%) | -$81.41 M(-2.0%) |
| Sep 2023 | - | -$14.28 M(-0.6%) | -$83.05 M(-1.0%) |
| Jun 2023 | - | -$14.36 M(-66.2%) | -$83.85 M(-3.1%) |
| Mar 2023 | - | -$42.45 M(+255.3%) | -$86.49 M(+59.0%) |
| Dec 2022 | -$54.40 M(+34.1%) | -$11.95 M(-20.8%) | -$54.40 M(+2.1%) |
| Sep 2022 | - | -$15.08 M(-11.3%) | -$53.26 M(+8.0%) |
| Jun 2022 | - | -$17.01 M(+64.2%) | -$49.30 M(+17.9%) |
| Mar 2022 | - | -$10.36 M(-4.2%) | -$41.80 M(+3.0%) |
| Dec 2021 | -$40.57 M(+47.7%) | -$10.81 M(-2.9%) | -$40.57 M(+11.2%) |
| Sep 2021 | - | -$11.13 M(+17.0%) | -$36.48 M(+12.6%) |
| Jun 2021 | - | -$9.51 M(+4.3%) | -$32.38 M(+10.2%) |
| Mar 2021 | - | -$9.12 M(+35.8%) | -$29.38 M(+6.9%) |
| Dec 2020 | -$27.48 M(-16.4%) | -$6.71 M(-4.6%) | -$27.48 M(-4.5%) |
| Sep 2020 | - | -$7.04 M(+8.3%) | -$28.76 M(-3.0%) |
| Jun 2020 | - | -$6.50 M(-9.9%) | -$29.65 M(-5.9%) |
| Mar 2020 | - | -$7.22 M(-9.7%) | -$31.50 M(-4.2%) |
| Dec 2019 | -$32.88 M(+42.3%) | -$8.00 M(+0.8%) | -$32.88 M(+40.6%) |
| Sep 2019 | - | -$7.93 M(-5.1%) | -$23.38 M(+5.9%) |
| Jun 2019 | - | -$8.36 M(-2.8%) | -$22.08 M(+4.7%) |
| Mar 2019 | - | -$8.60 M(-672.7%) | -$21.08 M(-8.7%) |
| Dec 2018 | -$23.10 M | $1.50 M(-122.6%) | -$23.10 M(-25.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$6.63 M(-9.9%) | -$30.83 M(-0.5%) |
| Jun 2018 | - | -$7.36 M(-30.7%) | -$31.00 M(+1.5%) |
| Mar 2018 | - | -$10.62 M(+70.3%) | -$30.55 M(+4.5%) |
| Dec 2017 | -$29.23 M(+19.8%) | -$6.23 M(-8.2%) | -$29.23 M(+3.6%) |
| Sep 2017 | - | -$6.79 M(-1.6%) | -$28.21 M(-0.4%) |
| Jun 2017 | - | -$6.91 M(-25.7%) | -$28.31 M(-1.2%) |
| Mar 2017 | - | -$9.29 M(+78.0%) | -$28.66 M(+17.5%) |
| Dec 2016 | -$24.40 M(+104.7%) | -$5.22 M(-24.3%) | -$24.40 M(+108.1%) |
| Sep 2016 | - | -$6.89 M(-4.9%) | -$11.72 M(+10.7%) |
| Jun 2016 | - | -$7.25 M(+44.0%) | -$10.59 M(+6.7%) |
| Mar 2016 | - | -$5.03 M(-167.6%) | -$9.92 M(-15.6%) |
| Dec 2015 | -$11.92 M(-43.4%) | $7.45 M(-229.4%) | -$11.75 M(-56.3%) |
| Sep 2015 | - | -$5.76 M(-12.5%) | -$26.88 M(+0.5%) |
| Jun 2015 | - | -$6.58 M(-4.1%) | -$26.75 M(+8.9%) |
| Mar 2015 | - | -$6.86 M(-10.6%) | -$24.56 M(+16.7%) |
| Dec 2014 | -$21.05 M(+15.8%) | -$7.67 M(+36.2%) | -$21.05 M(-2.3%) |
| Sep 2014 | - | -$5.63 M(+28.4%) | -$21.54 M(+1.2%) |
| Jun 2014 | - | -$4.39 M(+30.9%) | -$21.28 M(+10.8%) |
| Mar 2014 | - | -$3.35 M(-58.9%) | -$19.21 M(+8.2%) |
| Dec 2013 | -$18.18 M(+134.3%) | -$8.16 M(+51.7%) | -$17.75 M(+85.1%) |
| Sep 2013 | - | -$5.38 M(+131.9%) | -$9.59 M(+127.7%) |
| Jun 2013 | - | -$2.32 M(+22.7%) | -$4.21 M(+122.7%) |
| Mar 2013 | - | -$1.89 M | -$1.89 M |
| Dec 2012 | -$7.76 M | - | - |
FAQ
- What is Leap Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Leap Therapeutics?
- What is Leap Therapeutics annual EBIT year-on-year change?
- What is Leap Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Leap Therapeutics?
- What is Leap Therapeutics quarterly EBIT year-on-year change?
- What is Leap Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Leap Therapeutics?
- What is Leap Therapeutics TTM EBIT year-on-year change?
What is Leap Therapeutics annual earnings before interest & taxes?
The current annual EBIT of LPTX is -$81.41 M
What is the all time high annual EBIT for Leap Therapeutics?
Leap Therapeutics all-time high annual earnings before interest & taxes is -$7.76 M
What is Leap Therapeutics annual EBIT year-on-year change?
Over the past year, LPTX annual earnings before interest & taxes has changed by -$27.02 M (-49.67%)
What is Leap Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of LPTX is -$18.35 M
What is the all time high quarterly EBIT for Leap Therapeutics?
Leap Therapeutics all-time high quarterly earnings before interest & taxes is $7.45 M
What is Leap Therapeutics quarterly EBIT year-on-year change?
Over the past year, LPTX quarterly earnings before interest & taxes has changed by -$8.04 M (-77.90%)
What is Leap Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of LPTX is -$64.25 M
What is the all time high TTM EBIT for Leap Therapeutics?
Leap Therapeutics all-time high TTM earnings before interest & taxes is -$1.89 M
What is Leap Therapeutics TTM EBIT year-on-year change?
Over the past year, LPTX TTM earnings before interest & taxes has changed by +$17.16 M (+21.08%)